EP. 2: Moffitt’s Dr Julio Chavez Discusses New Treatment, Sequencing Options in DLBCL
May 22nd 2022
Julio Chavez, MD, MS, of Moffitt Cancer Center, spoke with The American Journal of Managed Care® (AJMC®) about how new approvals will alter decision making in the treatment of diffuse large B-cell lymphoma (DLBCL).